2,096 Shares in Cigna Group $CI Acquired by Phoenix Financial Ltd.

Phoenix Financial Ltd. purchased a new position in Cigna Group (NYSE:CIFree Report) in the 3rd quarter, Holdings Channel reports. The institutional investor purchased 2,096 shares of the health services provider’s stock, valued at approximately $605,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Valeo Financial Advisors LLC grew its stake in Cigna Group by 86,071.1% during the second quarter. Valeo Financial Advisors LLC now owns 3,475,282 shares of the health services provider’s stock valued at $1,148,859,000 after acquiring an additional 3,471,249 shares in the last quarter. Norges Bank bought a new position in shares of Cigna Group during the 2nd quarter valued at about $1,110,426,000. Arrowstreet Capital Limited Partnership grew its position in shares of Cigna Group by 24.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 2,508,740 shares of the health services provider’s stock valued at $829,339,000 after purchasing an additional 492,045 shares in the last quarter. Balyasny Asset Management L.P. increased its holdings in shares of Cigna Group by 1,057.2% in the second quarter. Balyasny Asset Management L.P. now owns 404,753 shares of the health services provider’s stock worth $133,803,000 after purchasing an additional 369,775 shares during the last quarter. Finally, Man Group plc increased its holdings in shares of Cigna Group by 215.5% in the second quarter. Man Group plc now owns 532,183 shares of the health services provider’s stock worth $175,929,000 after purchasing an additional 363,510 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on CI shares. Morgan Stanley restated an “overweight” rating and set a $355.00 price target on shares of Cigna Group in a report on Friday, October 31st. Deutsche Bank Aktiengesellschaft cut their target price on shares of Cigna Group from $415.00 to $301.00 and set a “buy” rating for the company in a report on Monday, November 3rd. TD Cowen set a $333.00 price target on shares of Cigna Group in a research report on Monday, December 15th. Zacks Research upgraded shares of Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Finally, Wells Fargo & Company reduced their target price on shares of Cigna Group from $354.00 to $300.00 and set an “equal weight” rating on the stock in a report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $330.36.

Get Our Latest Stock Analysis on Cigna Group

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani bought 4,134 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the completion of the purchase, the chief executive officer owned 157,935 shares in the company, valued at $38,201,317.80. This represents a 2.69% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.70% of the stock is currently owned by insiders.

Cigna Group Trading Up 1.0%

CI stock opened at $272.68 on Thursday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The stock has a market capitalization of $72.84 billion, a price-to-earnings ratio of 12.03, a price-to-earnings-growth ratio of 0.95 and a beta of 0.26. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.74. The firm’s fifty day simple moving average is $274.62 and its two-hundred day simple moving average is $284.95.

Cigna Group (NYSE:CIGet Free Report) last released its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.64 by $0.19. The firm had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. Cigna Group had a net margin of 2.29% and a return on equity of 18.80%. The business’s revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the business earned $7.51 EPS. As a group, analysts anticipate that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.